nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—GRIN2B—Parkinson's disease	0.626	0.747	CbGaD
Felbamate—CYP2E1—Parkinson's disease	0.212	0.253	CbGaD
Felbamate—GRIN2B—telencephalic ventricle—Parkinson's disease	0.00921	0.138	CbGeAlD
Felbamate—GRIN2B—nerve—Parkinson's disease	0.0058	0.0872	CbGeAlD
Felbamate—GRIN2A—nerve—Parkinson's disease	0.00507	0.0762	CbGeAlD
Felbamate—GRIN2B—hindbrain—Parkinson's disease	0.00435	0.0653	CbGeAlD
Felbamate—GRIN2A—hindbrain—Parkinson's disease	0.0038	0.0571	CbGeAlD
Felbamate—GRIN3A—forebrain—Parkinson's disease	0.00266	0.04	CbGeAlD
Felbamate—GRIN2B—brainstem—Parkinson's disease	0.00249	0.0374	CbGeAlD
Felbamate—GRIN2B—forebrain—Parkinson's disease	0.0024	0.0361	CbGeAlD
Felbamate—GRIN2A—brainstem—Parkinson's disease	0.00218	0.0327	CbGeAlD
Felbamate—GRIN2A—forebrain—Parkinson's disease	0.0021	0.0316	CbGeAlD
Felbamate—L-Phenylalanine—TH—Parkinson's disease	0.00173	1	CrCbGaD
Felbamate—GRIN2B—spinal cord—Parkinson's disease	0.00155	0.0233	CbGeAlD
Felbamate—GRIN3A—head—Parkinson's disease	0.00152	0.0229	CbGeAlD
Felbamate—GRIN2A—medulla oblongata—Parkinson's disease	0.00152	0.0228	CbGeAlD
Felbamate—GRIN3A—nervous system—Parkinson's disease	0.00144	0.0217	CbGeAlD
Felbamate—GRIN3A—central nervous system—Parkinson's disease	0.00139	0.0209	CbGeAlD
Felbamate—GRIN2A—midbrain—Parkinson's disease	0.00139	0.0209	CbGeAlD
Felbamate—GRIN2B—head—Parkinson's disease	0.00138	0.0207	CbGeAlD
Felbamate—GRIN2A—spinal cord—Parkinson's disease	0.00135	0.0204	CbGeAlD
Felbamate—GRIN2B—nervous system—Parkinson's disease	0.00131	0.0196	CbGeAlD
Felbamate—GRIN2B—central nervous system—Parkinson's disease	0.00126	0.0189	CbGeAlD
Felbamate—GRIN2B—cerebellum—Parkinson's disease	0.00123	0.0185	CbGeAlD
Felbamate—GRIN2A—head—Parkinson's disease	0.0012	0.0181	CbGeAlD
Felbamate—GRIN2A—nervous system—Parkinson's disease	0.00114	0.0171	CbGeAlD
Felbamate—GRIN3A—brain—Parkinson's disease	0.0011	0.0166	CbGeAlD
Felbamate—GRIN2A—central nervous system—Parkinson's disease	0.0011	0.0165	CbGeAlD
Felbamate—GRIN2A—cerebellum—Parkinson's disease	0.00107	0.0161	CbGeAlD
Felbamate—GRIN2B—brain—Parkinson's disease	0.000998	0.015	CbGeAlD
Felbamate—GRIN2A—brain—Parkinson's disease	0.000872	0.0131	CbGeAlD
Felbamate—CYP2E1—cardiovascular system—Parkinson's disease	0.000547	0.00822	CbGeAlD
Felbamate—CYP2E1—medulla oblongata—Parkinson's disease	0.000467	0.00702	CbGeAlD
Felbamate—CYP2E1—spinal cord—Parkinson's disease	0.000417	0.00626	CbGeAlD
Felbamate—CYP2E1—Tryptophan metabolism—MAOB—Parkinson's disease	0.000397	0.00419	CbGpPWpGaD
Felbamate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000396	0.00418	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000396	0.00418	CbGpPWpGaD
Felbamate—CYP2C19—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00039	0.00411	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000388	0.0041	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000388	0.0041	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NRTN—Parkinson's disease	0.000386	0.00407	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—DLG1—Parkinson's disease	0.00038	0.00401	CbGpPWpGaD
Felbamate—GRIN2B—Reelin signaling pathway—MAPK8—Parkinson's disease	0.000378	0.00399	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000376	0.00397	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPT—Parkinson's disease	0.000374	0.00394	CbGpPWpGaD
Felbamate—CYP2E1—head—Parkinson's disease	0.00037	0.00557	CbGeAlD
Felbamate—CYP2E1—nervous system—Parkinson's disease	0.000351	0.00528	CbGeAlD
Felbamate—GRIN2A—Neuronal System—GRIK1—Parkinson's disease	0.00035	0.00369	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000341	0.0036	CbGpPWpGaD
Felbamate—CYP2E1—central nervous system—Parkinson's disease	0.000338	0.00508	CbGeAlD
Felbamate—GRIN2B—Axon guidance—DLG1—Parkinson's disease	0.000337	0.00356	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000337	0.00355	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000333	0.00351	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—APOE—Parkinson's disease	0.000332	0.0035	CbGpPWpGaD
Felbamate—CYP2E1—cerebellum—Parkinson's disease	0.00033	0.00497	CbGeAlD
Felbamate—GRIN2B—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00033	0.00349	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.000329	0.00347	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00032	0.00338	CbGpPWpGaD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000319	0.00336	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000298	0.00314	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—GRIK2—Parkinson's disease	0.000298	0.00314	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—GRIK1—Parkinson's disease	0.000298	0.00314	CbGpPWpGaD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000291	0.00308	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00029	0.00306	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—SLC18A2—Parkinson's disease	0.000288	0.00304	CbGpPWpGaD
Felbamate—CYP3A4—nervous system—Parkinson's disease	0.000283	0.00425	CbGeAlD
Felbamate—GRIN2B—Alzheimers Disease—APOE—Parkinson's disease	0.000282	0.00298	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000273	0.00288	CbGpPWpGaD
Felbamate—CYP3A4—central nervous system—Parkinson's disease	0.000272	0.00409	CbGeAlD
Felbamate—CYP2E1—brain—Parkinson's disease	0.000268	0.00403	CbGeAlD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000268	0.00283	CbGpPWpGaD
Felbamate—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000266	0.00281	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—GDNF—Parkinson's disease	0.000264	0.00279	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000262	0.00277	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00026	0.00275	CbGpPWpGaD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000256	0.00271	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000256	0.0027	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000253	0.00267	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—GRIK2—Parkinson's disease	0.000253	0.00267	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00025	0.00264	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000248	0.00261	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000247	0.0026	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—SLC18A2—Parkinson's disease	0.000245	0.00259	CbGpPWpGaD
Felbamate—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000244	0.00257	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—DLG1—Parkinson's disease	0.000241	0.00254	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000238	0.00252	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000235	0.00248	CbGpPWpGaD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000234	0.00247	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000232	0.00245	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000231	0.00244	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CHRNA4—Parkinson's disease	0.000228	0.00241	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BDNF—Parkinson's disease	0.000222	0.00235	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00022	0.00232	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000219	0.00231	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000218	0.0023	CbGpPWpGaD
Felbamate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000217	0.00229	CbGpPWpGaD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000217	0.00229	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—IL1B—Parkinson's disease	0.000212	0.00223	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—CASP3—Parkinson's disease	0.000211	0.00223	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00021	0.00221	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00021	0.00221	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—HSPA8—Parkinson's disease	0.000209	0.00221	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000208	0.0022	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000201	0.00212	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000201	0.00212	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—NGF—Parkinson's disease	0.000197	0.00208	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—DLG4—Parkinson's disease	0.000196	0.00207	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—CHRNA4—Parkinson's disease	0.000194	0.00205	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000193	0.00204	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—GRIN2B—Parkinson's disease	0.000192	0.00202	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—SLC6A3—Parkinson's disease	0.000189	0.00199	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—GDNF—Parkinson's disease	0.000188	0.00199	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000188	0.00198	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000184	0.00194	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000184	0.00194	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000182	0.00192	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—IL1B—Parkinson's disease	0.00018	0.0019	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—CASP3—Parkinson's disease	0.000179	0.00189	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000178	0.00188	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—HSPA8—Parkinson's disease	0.000178	0.00188	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000177	0.00187	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000168	0.00178	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—DLG4—Parkinson's disease	0.000167	0.00176	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000166	0.00175	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—SLC6A3—Parkinson's disease	0.000161	0.0017	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—COMT—Parkinson's disease	0.000161	0.0017	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MAOA—Parkinson's disease	0.00016	0.00168	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000159	0.00168	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—HSPA8—Parkinson's disease	0.000158	0.00166	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTA4—Parkinson's disease	0.000155	0.00164	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TNF—Parkinson's disease	0.000153	0.00162	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000153	0.00161	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000149	0.00157	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—DLG4—Parkinson's disease	0.000148	0.00156	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000145	0.00154	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000141	0.00149	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—MAOB—Parkinson's disease	0.000138	0.00146	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—COMT—Parkinson's disease	0.000137	0.00144	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000136	0.00144	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MAOA—Parkinson's disease	0.000136	0.00143	CbGpPWpGaD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000131	0.00138	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—Parkinson's disease	0.00013	0.00138	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000125	0.00132	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000124	0.00131	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000121	0.00127	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00012	0.00126	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000118	0.00125	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ABL1—Parkinson's disease	0.000118	0.00124	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HSPA8—Parkinson's disease	0.000113	0.00119	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000112	0.00118	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—Parkinson's disease	0.000111	0.00117	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000111	0.00117	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000109	0.00115	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000107	0.00113	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—DLG4—Parkinson's disease	0.000106	0.00111	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	0.000103	0.00108	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000102	0.00108	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000101	0.00107	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000101	0.00107	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	9.99e-05	0.00105	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	8.97e-05	0.000947	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ABL1—Parkinson's disease	8.41e-05	0.000888	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	8.2e-05	0.000866	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	7.92e-05	0.000836	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.81e-05	0.000825	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—COMT—Parkinson's disease	7.78e-05	0.000822	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	7.75e-05	0.000818	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	7.73e-05	0.000816	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	7.68e-05	0.00081	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	7.64e-05	0.000807	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	7.25e-05	0.000765	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	7.19e-05	0.000759	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.15e-05	0.000754	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	7.12e-05	0.000751	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	7.09e-05	0.000749	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	7.02e-05	0.000741	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.75e-05	0.000713	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	6.63e-05	0.0007	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	6.41e-05	0.000677	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—COMT—Parkinson's disease	6.01e-05	0.000634	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	5.98e-05	0.000631	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	5.96e-05	0.000629	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	5.92e-05	0.000625	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	5.89e-05	0.000622	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—INS—Parkinson's disease	5.56e-05	0.000587	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	5.49e-05	0.00058	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	5.42e-05	0.000572	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ND3—Parkinson's disease	5.05e-05	0.000533	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MCCC1—Parkinson's disease	5.05e-05	0.000533	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	4.76e-05	0.000503	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TALDO1—Parkinson's disease	4.75e-05	0.000501	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—OMD—Parkinson's disease	4.75e-05	0.000501	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.7e-05	0.000496	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	4.5e-05	0.000475	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.36e-05	0.00046	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.3e-05	0.000454	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GCH1—Parkinson's disease	4.29e-05	0.000453	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.14e-05	0.000437	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ND3—Parkinson's disease	3.89e-05	0.000411	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MCCC1—Parkinson's disease	3.89e-05	0.000411	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—DBH—Parkinson's disease	3.83e-05	0.000404	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FBP1—Parkinson's disease	3.83e-05	0.000404	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GBA—Parkinson's disease	3.83e-05	0.000404	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TALDO1—Parkinson's disease	3.66e-05	0.000386	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—OMD—Parkinson's disease	3.66e-05	0.000386	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.61e-05	0.000381	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.59e-05	0.000379	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.59e-05	0.000379	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.56e-05	0.000376	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.54e-05	0.000374	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	3.47e-05	0.000366	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—Parkinson's disease	3.41e-05	0.000359	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GCH1—Parkinson's disease	3.31e-05	0.00035	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.3e-05	0.000349	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.26e-05	0.000344	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—Parkinson's disease	3.01e-05	0.000318	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.99e-05	0.000315	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FBP1—Parkinson's disease	2.95e-05	0.000312	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—DBH—Parkinson's disease	2.95e-05	0.000312	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GBA—Parkinson's disease	2.95e-05	0.000312	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—DDC—Parkinson's disease	2.81e-05	0.000296	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.65e-05	0.00028	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—Parkinson's disease	2.43e-05	0.000257	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.39e-05	0.000252	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.36e-05	0.000249	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.34e-05	0.000247	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ND3—Parkinson's disease	2.34e-05	0.000247	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.2e-05	0.000232	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—OMD—Parkinson's disease	2.2e-05	0.000232	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—DDC—Parkinson's disease	2.17e-05	0.000229	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.09e-05	0.00022	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.05e-05	0.000216	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.02e-05	0.000213	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.99e-05	0.00021	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.84e-05	0.000194	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.82e-05	0.000192	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.77e-05	0.000187	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DBH—Parkinson's disease	1.77e-05	0.000187	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GBA—Parkinson's disease	1.77e-05	0.000187	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.76e-05	0.000185	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.74e-05	0.000183	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.72e-05	0.000182	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.59e-05	0.000168	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TH—Parkinson's disease	1.57e-05	0.000165	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.5e-05	0.000159	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.36e-05	0.000143	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—COMT—Parkinson's disease	1.33e-05	0.000141	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.33e-05	0.00014	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.32e-05	0.00014	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.32e-05	0.00014	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.31e-05	0.000138	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DDC—Parkinson's disease	1.3e-05	0.000138	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.25e-05	0.000132	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.24e-05	0.000131	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.23e-05	0.00013	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.23e-05	0.000129	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.22e-05	0.000129	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TH—Parkinson's disease	1.21e-05	0.000127	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.17e-05	0.000123	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.16e-05	0.000122	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.11e-05	0.000117	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.1e-05	0.000116	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.08e-05	0.000114	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—COMT—Parkinson's disease	1.03e-05	0.000108	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.02e-05	0.000108	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.02e-05	0.000108	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.01e-05	0.000106	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APOE—Parkinson's disease	1e-05	0.000106	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—Parkinson's disease	9.68e-06	0.000102	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—Parkinson's disease	9.39e-06	9.91e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPX1—Parkinson's disease	8.99e-06	9.49e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—INS—Parkinson's disease	8.56e-06	9.03e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—Parkinson's disease	8.3e-06	8.76e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.15e-06	8.6e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CTGF—Parkinson's disease	8e-06	8.44e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APOE—Parkinson's disease	7.73e-06	8.16e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.45e-06	7.87e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.37e-06	7.78e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TH—Parkinson's disease	7.26e-06	7.67e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYCS—Parkinson's disease	6.97e-06	7.36e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—INS—Parkinson's disease	6.6e-06	6.97e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—COMT—Parkinson's disease	6.18e-06	6.52e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.15e-06	6.49e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.13e-06	6.47e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.06e-06	6.4e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.82e-06	6.14e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.65e-06	5.96e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.41e-06	5.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.99e-06	5.27e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APOE—Parkinson's disease	4.65e-06	4.91e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—INS—Parkinson's disease	3.97e-06	4.19e-05	CbGpPWpGaD
